framycetin has been researched along with Bone Neoplasms in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (33.33) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 2 (66.67) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Datta, NS; Liao, J; McCauley, LK; Schneider, A | 1 |
| Brown, EM; Butters, RR; Chattopadhyay, N; Kifor, O; Sanders, JL; Yamaguchi, T | 1 |
| Parrish, FF | 1 |
3 other study(ies) available for framycetin and Bone Neoplasms
| Article | Year |
|---|---|
Extracellular calcium as a candidate mediator of prostate cancer skeletal metastasis.
Topics: Bone Neoplasms; Calcium; Calcium Signaling; Cell Adhesion; Cell Growth Processes; Cell Line, Tumor; Cyclic AMP; Cyclin D1; Humans; Male; Neomycin; Prostatic Neoplasms; Proto-Oncogene Proteins c-akt; Receptors, Calcium-Sensing; RNA Interference; Transfection | 2006 |
Extracellular calcium-sensing receptor expression and its potential role in regulating parathyroid hormone-related peptide secretion in human breast cancer cell lines.
Topics: Blotting, Northern; Blotting, Western; Bone Neoplasms; Breast Neoplasms; Calcium; Humans; Immunohistochemistry; Neomycin; Parathyroid Hormone-Related Protein; Proteins; Receptors, Calcium-Sensing; Receptors, Cell Surface; Reverse Transcriptase Polymerase Chain Reaction; RNA, Messenger; Spermine; Transforming Growth Factor beta; Tumor Cells, Cultured | 2000 |
Allograft replacement of all or part of the end of a long bone following excision of a tumor.
Topics: Adolescent; Adult; Bacitracin; Bone Neoplasms; Bone Transplantation; Cadaver; Chondrosarcoma; Femoral Neoplasms; Fibrosarcoma; Giant Cell Tumors; Graft Rejection; Humans; Humerus; Ligaments, Articular; Methods; Middle Aged; Neomycin; Osteosarcoma; Postoperative Complications; Strontium Isotopes; Tendons; Tibia; Transplantation, Homologous | 1973 |